The ACIP votes to allow parental choice regarding the timing and necessity of the hepatitis B vaccine for newborns.

Medical influencers and social media, having changed the ways in which physicians communicate, now carry certain ethical responsibilities.

Adjunct corticosteroids probably reduce short-term mortality in adults with severe pneumonia or acute respiratory distress syndrome.

A newly developed primary care clinical pathway for bronchiolitis management in young children successfully reduced bronchodilator and steroid use.

Drug–induced liver injury appears more common in patients on tuberculosis therapy with chronic hepatitis C virus infection.

A new alert from the FDA warns that some sensors from Abbott may give incorrect blood sugar readings, which could lead to unsafe treatment decisions.

Fatty acid abnormalities and EFAD biomarkers are common in patients with cystic fibrosis who have severe CFTR genotypes.

Inhaled Technosphere insulin (TI) vs subcutaneous RAA did not meet the noninferiority margin for glycated HbA1c in youth with diabetes.

Continuous positive airway pressure (CPAP) termination rates among patients with OSA are affected by geographic disparities.

The FDA is facing even more leadership changes as drug regulator Dr Richard Pazdur prepares to retire at the end of the month.

CHEST guidelines on biologic management in severe adult asthma offers recommendations on choosing and switching among biologic therapies.

Maternal cardiovascular health (CVH) before and during pregnancy is affected by the patient's race and ethnicity.